Delivery Order SPE2DE24D0013-SPE2D626F5092
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The U.S. Defense Logistics Agency, operating under its Medical Supply Chain division, awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on September 25, 2025, with an ultimate completion date of October 9, 2025. The contract, designated as SARS-COV-2 FLU RSV 10S, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. This delivery order carries no set-aside designation and represents a discrete procurement under Cepheid's broader federal...
- The Defense Logistics Agency issued a $34,223.80 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies and services. The contract, designated as XPCOV2/FLU/RSV-10, carries an ultimate completion date of September 22, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order does not utilize a set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Defense Medical Supply Chain has awarded a $10,380 firm fixed-price delivery order to Cepheid Inc. for COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic testing solutions. The contract, designated as delivery order 4568136312, was awarded on May 2, 2025, with an ultimate completion date of May 9, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of the federal...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $5,440 to Cepheid Inc. on August 25, 2025, for the supply of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 2, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a continuation of Cepheid's established role...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F5092Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $6,732.00 firm fixed-price delivery order to Cepheid Inc. on October 27, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies. The contract, which carries no set-aside designation, is scheduled for completion by November 10, 2025, with performance to be executed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a routine procurement of molecular diagnostic reagents and test kits from the contractor's established portfolio of respiratory pathogen detection solutions, leveraging Cepheid's GeneXpert diagnostic platform technology. Cepheid has established itself as a primary federal supplier of molecular diagnostic systems and reagents across multiple healthcare agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company's federal contracting presence is particularly substantial within the VA system, where Cepheid holds two significant Indefinite Delivery Contracts valued at $6.7 million and $32.8 million respectively, which generate numerous delivery orders for diagnostic reagents and testing supplies. The current DLA Medical Supply Chain award reflects Cepheid's competitive positioning in federal molecular diagnostics procurement and its role in supporting government agencies' infectious disease testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 10/27/25 |